Li Zhang
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06165380) | Li Zhang | 2023-10-23 |
| SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC (NCT05583409) | Li Zhang | 2023-01-01 |
Track Li Zhang automatically
Every clearance here is in the API, with alerts when new ones post.